Company / Inventory
Amphstar Pharmaceuticals, Inc. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$176.9M
FY2025
5-year range
$92.8M / $176.9M
FY2021-FY2025
Trend
+15.1%
vs FY2024
Sector context
#31 of 105
Health Care
What the data says
At $177M, Amphstar Pharmaceuticals, Inc.'s inventory ranks #31 of 105 in the Health Care sector. Inventory has increased for 4 consecutive years, from $93M in FY2021 to $177M in FY2025.
Based on SEC 10-K filings.
$177M in FY2025 with a 5-year CAGR of +12.8%.
Improved from $106M to $177M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +19.5%
- 5-Year CAGR
- +12.8%
- 10-Year CAGR
- -
Sector benchmark
#31 of 105 in Health CareTop 30% of 105This company $176.9M Sector average $885.3M
▼
-80.0% below sector average
Key checks
Key Insights
- Amphstar Pharmaceuticals, Inc.'s inventory has grown for 4 consecutive years.
- 5-year CAGR of +12.8%, indicating consistent growth.
- In FY2025, inventory increased 15.1% year-over-year.
- Ranks #31 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $176.9M | +15.1% |
| FY2024 | $153.7M | +45.3% |
| FY2023 | $105.8M | +2.2% |
| FY2022 | $103.6M | +11.6% |
| FY2021 | $92.8M | -4.2% |
| FY2020 | $96.8M | -12.4% |
| FY2019 | $110.5M | +59.4% |
| FY2018 | $69.3M | +9.0% |
| FY2017 | $63.6M | -20.2% |
| FY2016 | $79.8M | +12.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026